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fungal aAbstract Mannich bases and thiosemicarbazide individually show antimicrobial, antifungal, anti-
convulsant, antimalarial, analgesic and anti-inﬂammatory type of varied pharmacological activities.
The novelty of the present work is the synthesis of mannich bases of thiosemicarbazide as mutual
prodrugs. In step-1, mannich bases are synthesized using aldehyde, ketones and amines with ali-
phatic, aromatic, cyclic and heterocyclic nature. In step-2, the synthesized bases were condensed
with thiosemicarbazide to form mannich bases of thiosemicarbazide. Structural characterization
of synthesized compounds was done using IR, mass and H-NMR spectroscopy. The compounds
were screened for anti-fungal activity using BHI (brain heart infusion) broth dilution method
against Candida albicans and Apergillus niger. Docking of synthesized compounds was done on
CYP51A1, P45014DM (Lanosterol 14 a-demethylase enzyme) using Vlife MDS 3.5 to conform
the mechanism of antifungal activity. Docking study showed a strong hydrophobic interaction
between amino acid residues Arganine (ARG141), Glutamine (GLU146), Leucine (LEU54), Lycine
(LYC227), and Threonine (THR147) with the carbon of ketone, nitrogen of amine and sulfur of
thiosemicarbazide. Strong Vander wall’s interactions are also observed with the carbon of ketone,
nitrogen of amine and sulfur of thiosemicarbazide.
Analogs with aromatic and substituted aromatic aldehydes showed least activity, while analogs
with aliphatic aldehyde, ketones and amines showed greater activity in C. albicans compared to
A. niger. Analogs having morpholine as amine showed comparable activity in both. Compounds
K17, K18, K19, and K20 have shown comparable highest activities.
Crown Copyright ª 2013 Published by Elsevier Ltd. All rights reserved.231 2637286, mobile: +91
iffmail.com (S.A. Pishawikar).
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Infectious diseases caused by bacteria and fungi affect millions
of people worldwide. Systematic programs to discover and de-
velop new antibiotics and antifungals, are the need of the hour
due to considerable extent of development of resistance by
organisms to the existing drugs used against them. Further,
the need has arisen largely due to advent of HIV, which hasreserved.
ynthesis, docking and in-vitro screening of mannich bases of
emistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.10.016
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2 S.A. Pishawikar, H.N. Moreincreased the numbers of profoundly and chronically immune
suppressed patients, who are susceptible to both serious inva-
sive and superﬁcial fungal infections. The development of new
agents may provide additional options for the treatment of
fungal infections and may help to overcome the limitations
of current treatments (Denning, 1991).
By deﬁnition, mutual prodrugs are carrier-linked prodrugs
consisting of two pharmacologically active agents coupled to-
gether so that each acts as a promoiety for the other agent and
vice versa. Individually mannich bases and thiosemicarbazide
show varied pharmacological activities such as, anticancer,
antimicrobial, antifungal, anticonvulsant, antimalarial, analge-
sic and anti-inﬂammatory. Present work has used the concept
of mutual prodrug to synthesize mannich bases of thiosemicar-
bazide as mutual prodrug and screening them as anti-fungal
agents (Bhosle et al., 2006; Pandeya et al., 1999, 2003).
The mannich base is an end product in the mannich
reaction, which is nucleophilic addition reaction of a non-enol-
izable aldehyde and any primary or secondary amine to
produce resonance stabilized imine (iminium ion or imine salt).
In the synthesis of mannich bases, generally the use of
thiosemicarbazide is done as amine component, but the
novelty of the present work is that, in step-1 successful synthe-
sis of a number of mannich bases was done using aldehyde,
ketones and amines with aliphatic, aromatic, cyclic and hetero-
cyclic nature. In step-2, synthesized mannich bases were con-
densed with thiosemicarbazide to form mannich bases of
thiosemicarbazide (Van de Kamp and Mosettig, 1936; March,
1977; Waring, 1979; Mannich and Krosche, 1912; Thompson,
1968).
Computational methodologies have become a crucial
component of many drug discovery programs, from hit identi-
ﬁcation to lead optimization. One key methodology is docking
of small molecules to protein binding sites, pioneered during
the early 1980s. The docking process involves the prediction
of ligand conformation and orientation (or posing) within a
targeted binding site. The two aims of docking studies are
accurate structural modeling and correct prediction of activity.
Docking studies have become a scientiﬁc approach for the
study of macromolecular structures and interactions. Macro-
molecular modeling by docking studies provides most detailed
possible view of drug–receptor interaction and has created a
new rational approach to drug design, where the structure of
drug is designed based on its ﬁt to three dimensional structures
of a receptor site. On the basis of docking scores one can pre-
dict the amount of activity that will be shown by compounds.
To conform the mechanism of antifungal activity of synthe-
sized compounds, docking of synthesized compounds was per-
formed on the structure of Lanosterol 14 a-demethylase
(CYP51A1, P45014DM) an enzyme from cytochrome P450
family that catalyzes the oxidative removal of the 14a-methyl
group of lanosterol, an essential step in the production of
sterols. Inhibition of this step leads to inhibition of synthesis
of ergosterol, a very essential component of fungal cell mem-
brane. For docking study Vlife MDS 3.5 was used (Lengauer
and Rarey, 1996; Kitchen et al., 2004).
The characterization of synthesized compounds was done
by IR and H NMR. The compounds were screened for
antifungal activity using Brain heart infusion (BHI) broth dilu-
tion method using Candida albicans (ATCC Code 10231),
Apergillus niger. (ATCC Code 16404) and using concentration
of Fluconazloe (30 lg/ml) as standard drug (Andrews, 2001;Please cite this article in press as: Pishawikar, S.A., More, H.N. S
thiosemicarbazide for anti-fungal activity. Arabian Journal of ChReport of the Working, 1991; Silverman, 2004; Williams
et al., 2007; Committee, 1997; Winstanley et al., 1994; Lennette
et al., 1985).
2. Methods and materials
Scheme of Synthesis:-2.1. Step-1 synthesis of mannich base
Proportion of three reactants used for reactions was 1.00
molecular equivalent of carbonyl compound (ketone),
1.05–1.10 molecular equivalent of amine in the form of
hydrochloride salt and 1.5–2.0 molecular equivalent of
aldehyde.
2.2. Procedure
Amine was taken in a ﬂat bottom ﬂask and converted into
hydrochloride salt using concentrated hydrochloric acid, for-
mation of salt is conﬁrmed by the use of Congo red paper.
To this were added ketone and aldehyde. The reaction mixture
was exposed to mechanical stirring. For some reactions heat-
ing on water bath was done.
Optimization of reaction conditions with respect to time
and temperature was done on individual basis for each reac-
tion. Time required varied from 30 min to 12–14 h, with tem-
perature conditions varying from room temperature with
mechanical stirring, to heating on water bath at temperatureynthesis, docking and in-vitro screening of mannich bases of
emistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.10.016
Table 1 Synthesized compounds
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Sr. No. Code R R1 R2 R3
01 K1 CH3 H C2H5 C2H5
02 K2 CH3 H CH3 CH3
03 K3 CH3 CH3CH2 CH3CH2CH2 CH3CH2CH2
04 K4 CH3CH2 CH3CH2CH2 CH2CH2OH CH2CH2OH
05 K5 CH3CH2CH2 CH3–CH–CH3 CH3CH2CH2CH2 CH3CH2CH2CH2
06 K6
O
CH3CH2 CH3CH2CH2 CH3CH2CH2
07 K7
O Cl
C2H5 C2H5
08 K8 CH3 CH3CH2CH2 CH3CH2CH2
09 K9 CH3
O
CH3CH2CH2 CH3CH2CH2
10 K10 CH3
O
CH3CH2CH2 CH3CH2CH2
11 K11
OCH3
CH3CH2CH2 CH2CH2OH CH2CH2OH
12 K12
O
CH3CH2 C2H5 C2H5
13 K13 O2N
H C2H5 C2H5
14 K14 H C2H5 C2H5
15 K15 O H C2H5 C2H5
16 K16 CH3
Cl
C2H5 C2H5
17 K17
Cl
O
H C2H5 C2H5
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Table 1 (continued)
Sr. No. Code R R1 R2 R3
18 K18 CH3 H
O N
19 K19 CH3CH2CH2 H
O N
20 K20 H
O N
21 K21 O H
O N
22 K22 CH3
C l O N
23 K23 CH3
O O N
24 K24
O
H
O N
25 K25
CH CH
H
O N
Table 2 Physicochemical data of synthesized compounds.
Code of compound Color Solubility M.P. (C) % Yield Rf value
K1 Green EtOH 120–122C 68 0.5
K2 Light green EtOH 84–88 72 0.6
K3 Mahogany EtOH 98–104 67 0.5
K4 Maroon EtOH 88–92 62 0.6
K5 Flattery brown EtOH 116–118 69 0.6
K6 Drab EtOH 84–86 78 0.5
K7 Arsenic EtOH 134–138 24 0.7
K8 Orange EtOH 198–200 38 0.6
K9 Bistre brown EtOH 200–202 43 0.6
K10 Orange EtOH 120–124 58 0.7
K11 Light orange EtOH 180–182 79 0.8
K12 Maroon EtOH 186–188 83 0.5
K13 Light red EtOH 130–134 69 0.7
K14 Light red EtOH 186–188 74 0.6
K15 Light orange EtOH 220–226 86 0.9
K16 Earth yellow EtOH 140–142 54 0.6
K17 Drab EtOH 138–140 88 0.7
K18 Dark orange EtOH 112–116 65 0.7
K19 Light orange EtOH 118–120 60 0.6
K20 Crimson EtOH 180–184 66 0.8
K21 Dark orange EtOH 226–228 59 0.7
K22 Light brown EtOH 123–126 44 0.8
K23 Orange EtOH 128–130 56 0.7
K24 Brown EtOH 113–116 71 0.6
K25 Dark brown EtOH 206–210 71 0.6
4 S.A. Pishawikar, H.N. More
Please cite this article in press as: Pishawikar, S.A., More, H.N. Synthesis, docking and in-vitro screening of mannich bases of
thiosemicarbazide for anti-fungal activity. Arabian Journal of Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.10.016
Synthesis, docking and in-vitro screening of mannich bases of thiosemicarbazide for anti-fungal activity 5between 80 and 100 C depending upon the complexity of
reactants.
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Simple condensation reaction was carried out between synthe-
sized mannich bases and one mole quantity of thiosemicarba-
zide in the presence of alcohol as solvent with reﬂuxation on
boiling water bath for around half an hour to form mannich
bases of thiosemicarbazide.R
O
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Synthesized compounds are shown in Table 1.
2.4. Characterization
Physicochemical characterization of the synthesized com-
pounds was done by the estimation of melting point and Rf
values by TLC. Results are mentioned in Table 2.
Structural characterization was done by using IR, mass
and H NMR. Representative results of some proto typeFigure 1 Representative interactions shown by K20 w
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erocyclic nature of reactant are as follows:2.5. Compound code
2.5.1. K2: – 4(1-propane 2 one) propane-N-methylamine
thiosemicarbazide
IRdata for said compoundareC–Hstretchingat2934.14 cm1,N–
H stretching at 3256.34 cm1, C‚S streatching at 1255.19 cm1,
C‚Nstretching at 1587.47 cm1, andCH2–CH2 at 2931.93 cm
1.
NMR Data:-1H-NMR (DMSO-d6) d ppm: 1.2–1.4 (m, 6H,
CH2), 2.2 (3H, CH3), 2.683 (6H, –N(CH3)2), 4.939 (s, 1H,
NH). MS (m/z): 165 (M+), [C8H16N3S-162].
2.5.2. K14 – 4(1-phenylethanone) propane-N-ethylamine
thiosemicarbazide
IR data for said compound are C–H stretching at 2924.44 cm
1, N–H stretching at 3239.85 cm1, C‚S stretching at
1239.47 cm1, C‚N stretching at 1597.67 cm1, CH2–CH2
at 2938.98 cm1.
NMR Data:-1H-NMR (DMSO-d6) d ppm: 1.2–1.6 (m, 6H,
CH2), 2.8–2.977 (10H, N(C2H5)2), 5.173 (s, 1H, NH), 7.498–
8.725 (4H,m, aromatic),MS (m/z): 295 (M+), [C15H23N4S-291].
2.5.3. K17 – 4(1-propane 2 one) propane-N-tetra hydro-1-4
oxazinel thiosemicarbazide
C‚N stretching at 1577.87 cm1, C‚S stretching at
1235.17 cm1, N–H stretching at 3246.94 cm1, CH2–CH2 at
2936.93 cm1.
NMR data:-1H-NMR (DMSO-d6) d ppm : 2.5–2.844
(m, 6H, CH2), 3.631–3.705 (3H, CH3), 5.171 (s, 1H, NH),
7.1–8.031 (m, 4H, morpholino proton), MS (m/z): 222 (M),
[C10H14N3SO-224].ith amino acid residues of CYP51A1, P45014DM.
ynthesis, docking and in-vitro screening of mannich bases of
emistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.10.016
6 S.A. Pishawikar, H.N. More2.5.4. Docking study
Lanosterol 14 a-demethylase is a cytochrome P450 family en-
zyme that catalyzes the oxidative removal of the 14a-methyl
group of lanosterol, an essential step in the production of ster-
ols. Inhibition of this step leads to inhibition of the synthesis ofFigure 3 Representative docking of K
Figure 2 Representative interactions show
Please cite this article in press as: Pishawikar, S.A., More, H.N. S
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brane. Hence it is a target for antifungal drugs.
CYP34A is also an enzyme from the cytochrome P450
family, which plays a role in fast metabolism of thiols and
thioamide type of compounds, inhibition of enzyme activity20 in CYP51A1, P45014DM pocket.
n by K20 with CYP51A1, P45014DM.
ynthesis, docking and in-vitro screening of mannich bases of
emistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.10.016
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for a prolonged period of time.
To conﬁrm the mechanism of antifungal activity of synthe-
sized compounds and study the potential interaction, docking
of synthesized compounds was performed on the pdb structure
of Lanosterol 14 a-demethylase (CYP51A1, P45014DM) using
Vlife MDS 3.5 as target. All synthesized molecules were
docked into the same binding site.
Docking study showed a strong hydrophobic interaction be-
tween amino acid residues, likeArganine (ARG141),Glutamine
(GLU146), Leucine (LEU54), Lycine (LYC227), andThreonine
(THR147) with the carbon of ketone, nitrogen of amine and sul-
fur of thiosemicarbazide at distances of 2.998, 4.193 and 4.354,
respectively and with hydrogen of aldehyde at 2.279.
Strong Vander wall’s interactions were observed with the
carbon of ketone, nitrogen of amine and sulfur of thiosemicar-
bazide. The amino acid residues involved are Aspartine
ASP175A, Glycine GLY176A, Lysine LYS227A, Arganine
ARG141B, Threonine THR147B and Phenyl alanine PHE58A,
which might be playing an important role in the selective bind-
ing of compounds with target. Figs. 1–3 show interactions be-
tween K20, the highest activity compound with target.
2.6. Estimation of antifungal activity (Andrews, 2001; Report
of the Working, 1991; Silverman, 2004; Williams et al., 2007;
Committee, 1997; Winstanley et al., 1994; Lennette et al., 1985;
Mac Faddin, 1985; N.C.C.L.S., 1990)
An anti-fungal activity screening is done to determine the
MIC (Minimum inhibitory concentrations), using Brain
Heart Infusion(BHI) broth dilution method to estimate
MIC of compounds using C. albicans (ATCC CodeTable 3 Anti-fungal activity of synthesized compounds.
Sr. No Product code Activity on C. albicans M
01 K1 31.25
02 K2 31.25
03 K3 31.25
04 K4 31.25
05 K5 31.25
06 K6 31.25
07 K7 31.25
08 K8 31.25
09 K9 62.5
10 K10 31.25
11 K11 250
12 K12 62.5
13 K13 16.6
14 K14 16.6
15 K15 16.6
16 K16 250
17 K17 4.0
18 K18 4.0
19 K19 16.6
20 K20 4.0
21 K21 31.25
22 K22 16.6
23 K23 16.6
24 K24 16.6
25 K25 16.6
Std. Fluconazloe 30
Please cite this article in press as: Pishawikar, S.A., More, H.N. S
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centration 30 lg/ml.
9 dilutions of each drug were done with BHI for MIC.
1. In the initial tube 20 microliter of drug was added into the
380 microliter of BHI broth.
2. For dilution 200 microliter of BHI broth was added into
the next 9 tubes separately.
3. Then from the initial tube 200 microliter was transferred to
the ﬁrst tube containing 200 microliter of BHI broth. This
was considered as 101 dilution.
4. From 101 diluted tube 200 microliter was transferred to
the second tube to make 102 dilution.
5. The serial dilution was repeated up to 109 dilution for
each drug.
6. From the maintained stock cultures of required organisms,
5 microliter was taken and added into 2 ml of BHI (brain
heart infusion) broth.
7. In each serially diluted tube 200 microliter of the above cul-
ture suspension was added.
8. The tubes were incubated for 24 h and observed for
turbidity3. Results
3.1. Results for synthetic scheme
As mannich bases and thiosemicarbazide individually show
varied pharmacological activities, the proposed work was car-
ried out with the intention of synthesis of mannich bases of thi-
osemicarbazide as mutual prodrugs. In step 1 successful
synthesis of mannich bases was done using aldehyde, ketonesIC (lg/ml) Activity on Apergillus niger. MIC (lg/ml)
31.25
31.25
31.25
31.25
62.5
62.5
62.5
62.5
62.5
62.5
31.25
250
62.5
62.5
62.5
62.5
31.25
16.6
8.3
16.6
62.5
16.6
16.6
16.6
16.6
16
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8 S.A. Pishawikar, H.N. Moreand amines with aliphatic, aromatic, cyclic and heterocyclic
nature. Optimization of reaction conditions for the synthesis
of mannich bases with respect to time and temperature had
to be done on individual basis. Time required for synthesis,
varied from 30 min to 12–14 h, with temperature condition
varying from room temperature with mechanical stirring to
temperature between 80 and 100 C on the basis of complexity
of the structures of reactants. Percentage yield of synthesized
compounds varied from 24% to 88 %. The TLC and spectral
analysis done for compounds conﬁrmed successful synthesis of
expected compounds.3.2. Results related to activity
The major components of the fungal cell wall are chitin, glu-
cans, polysaccharides and glycoproteins. The species speciﬁc
variations in composition of components exist, which were
conformed due to variations seen in activities shown by syn-
thesized compounds in C. albicans and A. niger.
Synthesized compounds were screened for antifungal activ-
ity using Brain Heart Infusion (BHI) broth dilution method to
estimate minimum inhibitory concentration for synthesized
compound using C. albicans and A. niger.
Mannich bases with alkyl components have shown compa-
rable activities in both microorganisms to the standard drug
used. Mannich bases of thiosemicarbazide having only alkyl
components have shown more or less comparable activity in
both C. albicans and A. niger. Compounds with morpholine
as amine component have shown greater activity on C. albi-
cans than on A. niger.
Highest activity is shown by the compound with ketone
having an unsubstituted aromatic ring, formaldehyde/parafor-
maldehyde and morpholine as amine component.
In compoundswith aldehyde other than formaldehyde/para-
formaldehyde when antifungal activity is concerned they show
lesser activity. Results of activity are mentioned in Table 3.
3.3. Results of docking study
For conﬁrmation of antifungal activity, docking study was
done on Lanosterol 14 a-demethylase CYP51A1, P45014DM
using Vlife MDS 3.5 as target. A low (negative) energy indi-
cates a stable system and thus a likely binding interaction.
Negative sign in docking score indicates an association of
minimum energy with further emphasis that the orientation
of synthesized compounds in the pocket of the said target
was proper. Compound K20 showed a docking score of
78.008461 while Original Ligand Score was 71.342323.
Docking study showed strong hydrophobic interaction be-
tween amino acid residues, like Arganine (ARG141), Gluta-
mine (GLU146), Leucine (LEU54), Lycine (LYC227), and
Threonine (THR147) with the carbon of ketone, nitrogen of
amine and sulfur of thiosemicarbazide at distances of 2.998,
4.193 and 4.354, respectively and with hydrogen of aldehyde
at 2.279. Also strong Vander wall’s interactions were observed
with carbon of ketone, nitrogen of amine and sulfur of thio-
semicarbazide. The amino acid residues involved are Aspartine
ASP175A, Glycine GLY176A, Lysine LYS227A, Arganine
ARG141B, Threonine THR147B and Phenylalanine PHE58A,
which might be playing an important role in selective binding
of compounds with target.Please cite this article in press as: Pishawikar, S.A., More, H.N. S
thiosemicarbazide for anti-fungal activity. Arabian Journal of ChThe overall results of synthesis, docking study and activity
leads to conformation that the protocol of plane of work to
synthesis of mannich bases of thiosemicarbazide as novel mu-
tual prodrug was successful.
4. Discussion
Complexity of aldehyde, ketones and amines played a signiﬁ-
cant role in the optimization of time, temperature and % yield
of synthesized compounds on individual basis. It was observed
that in the presence of formaldehyde or paraformaldehyde as
aldehyde, reaction goes to completion at a faster rate with bet-
ter yield of end product.
Screening of compounds for antifungal activity led to the
following observations,
(1) Mannich bases of thiosemicarbazide having only alkyl
components have shown more or less comparable activ-
ity in both C. albicans and A. niger.
(2) Acyl derivatives are found to be partly active.
(3) Mannich bases of Thiosemicarbazides formed from ali-
phatic carbonyl compounds showed good antifungal
activity against C. albicans compared to A. niger.
(4) Use of unsubstituted aromatic components in the syn-
thesis of mannich bases of thiosemicarbazide gave active
derivatives, but compounds with 3- and 4-substituted
aromatic ring showed to be less active.
(5) Highest activity was shown by thiosemcarbazides with
morpholine as amine and ketone component having aro-
matic nature.
(6) Mannich bases of thiosemicarbazide with aromatic alde-
hyde showed somewhat lesser activity than the thiosem-
icarbazone with aromatic ketones
(7) Mannich bases of thiosemicarbazide with heterocyclic
aldehydes showed comparable activity to alkyl derivatives.
In docking study speciﬁc structural features like the carbon
of ketone, nitrogen of amine and sulfur of thiosemicarbazide
present in compounds were found to be responsible for strong
interactions like strong hydrophobic, Vander wall’s interac-
tions and hydrogen bonding with amino acid residues from
chosen target. The result obtained conform the mechanism
of antifungal activity shown by the synthesized compounds.Acknowledgements
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